ENB-110e

N/A

Report date: 2024/07/24 17:42:11
NME

Base Information

Drug NameENB-110e
Drug Alias NameENB-110eENB110e
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseCholangitis, Sclerosing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai EnnovaBio Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai EnnovaBio Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseCholangitis, Sclerosing
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A